Eli Lilly & Co. (LLY)
Underlying price
$1,163.61+0.93% today
Stock stats
- Market cap
- $1.02T
- Previous close
- $1,152.93
- Open
- $1,144.49
- Day's range
- $1,134.41 – $1,170.89
- 52-week range
- $712.05 – $1,292.65
- Volume
- 1.18M
- Avg volume
- 2.43M
- P/E ratio
- 38.47
About Eli Lilly & Co.
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
- Ticker
- LLY
- Asset class
- Equity
- Tokenized by
- 3 issuers
- Sector
- Healthcare
- Industry
- Pharmaceutical Preparations
- Employees
- 50,000
- Website
- lilly.com
Eli Lilly & Co. FAQ
LLY is Eli Lilly & Co. stock, issued on Solana as a token that tracks the listed share. Each issuer mints its own version, so Eli Lilly & Co. trades here as 3 tokens rather than one.